New research from the University of Arizona Health Sciences suggests that terpenes found in cannabis plants could provide effective relief for fibromyalgia and post-surgical pain. The study, published in Pharmacological Reports, explained how these natural compounds can offer pain relief without the psychoactive effects associated with THC.
Terpenes are compounds found in many plants, giving them their unique aroma and flavor. In cannabis, they contribute to the plant’s distinct smell, but scientists are now uncovering their potential medical benefits.
Researchers tested four terpenes—geraniol, linalool, beta-caryophyllene, and alpha-humulene—on preclinical mouse models suffering from fibromyalgia and post-operative pain. The results showed that these terpenes significantly reduced pain levels, with geraniol being the most effective.
Unlike THC, which is the main psychoactive component in cannabis, terpenes provide pain relief without causing a “high.” This makes them a promising option for patients looking for alternative treatments without the mind-altering effects of traditional cannabis use.
Chronic pain affects millions of people worldwide, and opioids have long been the standard treatment. However, opioids come with serious risks, including addiction and dangerous side effects. The study’s findings suggest that terpenes could offer a natural and safer alternative for pain management.
Dr. John Streicher, a professor at the University of Arizona College of Medicine, explained that while terpenes may not be effective for acute pain—like a stubbed toe or a burn—they show strong potential for chronic pain conditions such as fibromyalgia.
Post-surgical pain is another area where opioids are commonly used. While they effectively reduce pain, they can lead to complications such as constipation, which increases the risk of post-surgical problems like adhesions. The study suggests that terpenes could be a better option, helping patients recover from surgery without the unwanted side effects of opioid use.
Researchers found that terpenes work by targeting the adenosine A2a receptor, a part of the nervous system involved in pain relief. This receptor is also influenced by caffeine, suggesting that terpenes may have a sedative effect. This mechanism is crucial for understanding how these compounds provide pain relief and could lead to further research into their full potential.
The University of Arizona study builds on previous research into the pain-relieving properties of cannabis-derived compounds. Dr. Streicher and his team have previously explored how terpenes affect pain from inflammation and chemotherapy-induced nerve damage. The latest findings expand this knowledge by demonstrating that terpenes can also relieve pain associated with fibromyalgia and surgical procedures.
ALSO READ: Scientist Reveals Plants “Scream” When Cut, Using Ultrasonic Devices
Fibromyalgia is a complex and poorly understood condition that causes widespread pain, fatigue, and cognitive difficulties. It affects up to 5% of the global population, with around 4 million adults in the United States suffering from the disorder.
Treatment options are currently limited, and many patients struggle to find effective pain relief. The discovery that cannabis-derived terpenes could help fibromyalgia patients offers new hope for those who have not found relief through traditional medications.
Dr. Streicher emphasized the importance of these findings, noting that fibromyalgia pain is challenging to treat. The research suggests that terpenes may provide an effective alternative for people who have not responded well to existing treatments. Since these compounds do not produce the psychoactive effects of THC, they could be a more accessible option for a wider range of patients.
The study’s findings open the door for further research into how terpenes can be used in medical treatments. Scientists believe that these compounds could be developed into new pain relief medications, offering a natural alternative to opioids and other traditional painkillers. More research is needed to determine the optimal dosage and delivery methods for terpene-based treatments.
Dr. Todd Vanderah, director of the Comprehensive Center for Pain & Addiction at the University of Arizona Health Sciences, highlighted the importance of studying natural compounds for medical applications.
He pointed out that many plant-based chemicals remain unexplored, and their potential benefits for human health are still being discovered. He compared the findings on terpenes to the development of Ozempic, a medication derived from a compound found in the Gila monster, showing how nature can provide groundbreaking medical treatments.
